Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.
Register for FREE Now
Stem cell therapy group Reneuron said it remains on track with the first patients having been dosed in two its clinical trials. The phase II trial fo...
Create a free LSE account to:
Already have an account? Sign In
Don't have an account? Register for FREE